Insmed | INSM - Umsatzerlöse





Der Umsatz Veränderung Datum
BioMarin Pharmaceutical USD 766M 109M 2026-03
Cytokinetics USD 19.35M 1.59M 2026-03
DBV Technologies USD 2.77M 1.31M 2025-09
Gilead Sciences USD 7B 930M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Novartis USD 13.11B 750M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03